Son Tran

Associate Director, Device Engineering

Son Tran is an Associate Director at Gilead Sciences with 17 years of device development experience. He is responsible for the development of the Sunlenca injection kit which is Gilead’s first combination product approved for long-acting HIV treatment in combination with other antiretroviral. Additionally, he is leading process improvement initiatives for the company’s design control process. His past experience includes development and commercialization of a variety of different combination products ranging from on-body injector to novel injection needles for ocular implant. He holds a B.S. in mechanical engineering from University of Utah.

Talks About
#products #medicals

Preferred Locations
#Northamerica